Gambacorti‐Passerini, C., Kantarjian, H. M., Kim, D., Khoury, H. J., Turkina, A. G., Brümmendorf, T. H., . . . Cortes, J. E. (2015). Long‐term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors. Am J Hematol.
Styl ChicagoGambacorti‐Passerini, Carlo, et al. "Long‐term Efficacy and Safety of Bosutinib in Patients With Advanced Leukemia Following Resistance/intolerance to Imatinib and Other Tyrosine Kinase Inhibitors." Am J Hematol 2015.
Citace podle MLAGambacorti‐Passerini, Carlo, et al. "Long‐term Efficacy and Safety of Bosutinib in Patients With Advanced Leukemia Following Resistance/intolerance to Imatinib and Other Tyrosine Kinase Inhibitors." Am J Hematol 2015.